These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34501351)

  • 1. Fecal Zonulin as a Noninvasive Biomarker of Intestinal Permeability in Pediatric Patients with Inflammatory Bowel Diseases-Correlation with Disease Activity and Fecal Calprotectin.
    Szymanska E; Wierzbicka A; Dadalski M; Kierkus J
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New noninvasive biomarkers of intestinal inflammation and increased intestinal permeability in pediatric inflammatory bowel diseases and their correlation with fecal calprotectin: a pilot study.
    Szymanska E; Bierla J; Dadalski M; Wierzbicka A; Konopka E; Cukrowska B; Kierkus J
    Minerva Gastroenterol (Torino); 2023 Dec; 69(4):504-510. PubMed ID: 35436840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease.
    Shimizu H; Ebana R; Kudo T; Sato T; Hara T; Hosoi K; Usami M; Yoshida M; Takeuchi I; Nakase H; Iwama I; Arai K; Shimizu T
    J Gastroenterol; 2022 May; 57(5):344-356. PubMed ID: 35165800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum zonulin in patients with inflammatory bowel disease: a pilot study.
    Caviglia GP; Dughera F; Ribaldone DG; Rosso C; Abate ML; Pellicano R; Bresso F; Smedile A; Saracco GM; Astegiano M
    Minerva Med; 2019 Apr; 110(2):95-100. PubMed ID: 30160088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal zonulin is elevated in Crohn's disease and in cigarette smokers.
    Malíčková K; Francová I; Lukáš M; Kolář M; Králíková E; Bortlík M; Ďuricová D; Štěpánková L; Zvolská K; Pánková A; Zima T
    Pract Lab Med; 2017 Dec; 9():39-44. PubMed ID: 29034305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study.
    Nakamura S; Imaeda H; Nishikawa H; Iimuro M; Matsuura M; Oka H; Oku J; Miyazaki T; Honda H; Watanabe K; Nakase H; Andoh A
    Intest Res; 2018 Oct; 16(4):554-562. PubMed ID: 30301337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FACTORS ASSOCIATED WITH CIRCULATING ZONULIN IN INFLAMMATORY BOWEL DISEASE.
    Lacombe LAC; Matiollo C; Rosa JSD; Felisberto M; Dalmarco EM; Schiavon LL
    Arq Gastroenterol; 2022; 59(2):238-243. PubMed ID: 35830035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study.
    Cenni S; Casertano M; Trani M; Pacella D; Martinelli M; Staiano A; Miele E; Strisciuglio C
    Eur J Pediatr; 2023 Mar; 182(3):1299-1308. PubMed ID: 36637538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of fecal calprotectin in monitoring activity of inflammatory bowel diseases.
    Knyazev OV; Kagramanova AV; Korneeva IA; Noskova KK; Belousov SV; Parfenov AI
    Ter Arkh; 2019 May; 91(4):53-61. PubMed ID: 31094477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of zonulin-related proteins with prevalent and incident inflammatory bowel disease.
    Wang X; Memon AA; Palmér K; Hedelius A; Sundquist J; Sundquist K
    BMC Gastroenterol; 2022 Jan; 22(1):3. PubMed ID: 34979917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
    Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
    Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting.
    Sarrabayrouse G; Elias A; Yáñez F; Mayorga L; Varela E; Bartoli C; Casellas F; Borruel N; Herrera de Guise C; Machiels K; Vermeire S; Manichanh C
    mSystems; 2021 Mar; 6(2):. PubMed ID: 33758031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal calprotectin as a marker of the severity of mucosal inflammation in children with inflammatory bowel disease.
    Dolinšek J; Rižnik P; Sabath L; Mičetić-Turk D
    Wien Klin Wochenschr; 2016 Apr; 128(7-8):253-9. PubMed ID: 26659704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the correlation between fecal calprotectin, blood markers and disease activity in pediatric inflammatory bowel disease.
    Plume JL; De A; Mutalib M
    Ann Gastroenterol; 2024; 37(4):436-441. PubMed ID: 38974077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methanogenic Archaea in the Pediatric Inflammatory Bowel Disease in Relation to Disease Type and Activity.
    Cisek AA; Szymańska E; Wierzbicka-Rucińska A; Aleksandrzak-Piekarczyk T; Cukrowska B
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation.
    Chung-Faye G; Hayee B; Maestranzi S; Donaldson N; Forgacs I; Sherwood R
    Inflamm Bowel Dis; 2007 Nov; 13(11):1374-8. PubMed ID: 17577247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.
    Walkiewicz D; Werlin SL; Fish D; Scanlon M; Hanaway P; Kugathasan S
    Inflamm Bowel Dis; 2008 May; 14(5):669-73. PubMed ID: 18240279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.